Search results
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 hours agoOpportunities: Expansion in emerging markets and potential for new product launches. Threats: Patent...
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Business Insider via Yahoo Finance· 6 hours agoZepbound is the new weight loss injection from Eli Lilly. It's the same drug that's in Mounjaro for...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 15 hours agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 13 hours agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that ...
Eli Lilly shares target raised by BMO Capital on recent earnings miss By Investing.com
Investing.com· 9 hours agoOn Tuesday, BMO Capital Markets adjusted its outlook on Eli Lilly and Company (NYSE:LLY), raising...
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 9 hours agoEli Lilly is Tuesday's IBD Stock Of The Day. Shares are rounding the corner to a breakout after...
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 12 hours agoImage source: The Motley Fool. Eli Lilly (NYSE: LLY) Q1 2024 Earnings Call Apr 30, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Earnings call: Eli Lilly raises 2024 outlook on strong Q1 performance By Investing.com
Investing.com· 8 hours agoEli Lilly and Company (NYSE:LLY) has reported a robust financial performance in the first quarter of 2024, with a significant increase in revenue and earnings per share. The ...
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 3 days agoMany of those that do earn approval end up falling short of sales expectations. However,...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
NBC Bay Area· 23 hours agoEli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance on strong sales of its blockbuster diabetes ...